FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to the field of medicine and chemical-pharmaceutical industry, specifically to a method for increasing the supply of lansoprazole to the bloodstream of a mammal when administered orally, comprising orally administering said mammal a solution of lansoprazole in the presence of 2R-dodecyl-2-(N,N-dimethylamino)-propionate or a salt thereof, having an enantiomeric purity of at least 70 %, to a pharmaceutical solution for oral administration, containing lansoprazole in a mixture with 2R-dodecyl-2-(N,N-dimethylamino)-propionate or a salt thereof, and a mixture of lansoprazole and 2R-dodecyl-2-(N, N-dimethylamino)-propionate or a salt thereof.
EFFECT: group of inventions provides an increase in the intake of lansoprazole in the bloodstream of a mammal when administered orally.
12 cl, 1 dwg, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STABLE CRYSTALLINE CHLORIDE MODIFICATIONS DOTAP | 2005 |
|
RU2463291C2 |
| METHOD FORASYMMETRICTRANSFORMATION OF SUBSTITUTED 2H-CHROMENE-3-CARBOXY ACIDS DUE TO DIFFERENTIAL SOLUBILITY | 2020 |
|
RU2792894C2 |
| STABILISED COMPOSITION FOR TREATING PSORIASIS | 2009 |
|
RU2526162C2 |
| PHARMACEUTICALLY ACCEPTABLE SALTS OF PYRILINDOLE ENANTIOMERS FOR USE IN MEDICINE | 2014 |
|
RU2706688C2 |
| METHODS AND COMPOSITIONS FOR RAYNAUD DISEASE TREATMENT | 2012 |
|
RU2633236C2 |
| METHOD OF TREATMENT OF PATIENTS WITH INFECTIONS INDUCED BY HEPATITIS B VIRUS | 1993 |
|
RU2157215C2 |
| DERIVATIVES OF N-HETEROCYCLYLMETHYLMENZAMIDES, OBTAINMENT AND APPLICATION IN THERAPY | 2004 |
|
RU2346945C2 |
| TENATOPAZOL (-)-ENANTIOMER, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND ITS USING | 2003 |
|
RU2310652C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING (S)-(-)-2-(4-ISOBUTYL- -PHENYL)-PROPIONATE SODIUM, METHOD OF SYNTHESIS OF 2-(4- -ISOBUTYLPHENYL)-PROPIONIC ACID SODIUM SALT ENANTIOMER, (S)-(-)-2-(4-ISOBUTYLPHENYL)-PROPIONATE SODIUM DIHYDRATE | 1992 |
|
RU2145219C1 |
| SUSTAINABLE CRYSTALLINE MODIFICATIONS OF CHLORIDE DOTAP | 2012 |
|
RU2627354C2 |
